Post by David Grey on Apr 24, 2020 12:36:16 GMT -5
A phase 3, multicenter, randomizd, double-blind, placebocontrolled, clinical study to assess the efficacy and safety of linzagolix in subjects with moderate to severe endometriosis associated pain.
304 Ne 1St Street
Old Town, FL 32626
(352) 490-4816
View Study Website
Sponsored By: Southeast Clinical Research.net
Stipend: $10 - $100
Length of Study: 60 weeks
Research Facility: Out-Patient
Gender: Both
Age: 1 - 100
Washout Period: 90 days from Last Dosing Date to Admission
Health Condition: Endometriosis
More Information: Diagnosed with pelvic endometriosis in the last 10 years with supporting documentation in medical records.
BMI of >/= 18 and regular menstral cycle.
Moderate to severe endometriosis associated pain during screening period reported in electronic diary with 75% completion of diary.
Call (352) 490-4816
304 Ne 1St Street
Old Town, FL 32626
(352) 490-4816
View Study Website
Sponsored By: Southeast Clinical Research.net
Stipend: $10 - $100
Length of Study: 60 weeks
Research Facility: Out-Patient
Gender: Both
Age: 1 - 100
Washout Period: 90 days from Last Dosing Date to Admission
Health Condition: Endometriosis
More Information: Diagnosed with pelvic endometriosis in the last 10 years with supporting documentation in medical records.
BMI of >/= 18 and regular menstral cycle.
Moderate to severe endometriosis associated pain during screening period reported in electronic diary with 75% completion of diary.
Call (352) 490-4816
